Specifications tableSubjectInfectious diseaseSpecific subject areaImmunological profiles of children with COVID-19 infectionType of dataTableHow data were acquiredChildren in Wuhan, China who were tested positive for SARS-CoV-2 by nasopharyngeal aspirate (NPA) reverse-transcriptase polymerase chain reactions (RT-PCR) were admitted to the Wuhan Children\'s Hospital between 21st January and 20th March 2020. Their hospital records and laboratory results were retrieved and analysed.Data formatRawParameters for data collectionAge, gender, complete blood counts, lymphocyte subset profiles, immunoglobulin profiles and cytokine profilesDescription of data collectionLaboratory data were retrospectively retrieved from the patients' hospital record.Data source locationInstitution: Wuhan Children\'s Hospital\
City/Town/Region: Wuhan\
Country: ChinaData accessibilityWith the articleRelated research articleXiong X, Chua GT, Chi S, et al. A Comparison Between Chinese Children Infected with COVID-19 and with SARS. *J Pediatr* 2020 doi: <https://doi.org/10.1016/j.jpeds.2020.06.041>[@bib0001]

Value of the data {#sec0001a}
=================

•The COVID-19 pandemic has caused more than 5 million people being infected and 350,000 people died [@bib0002]. Although the majority of paediatric cases have been reported to have mild symptoms, their haematological and immunological profiles has not been well described.•Understanding the differences in the haematological and immunological profiles between children with symptomatic and asymptomatic COVID-19 infections may help the utilization of targeted therapies in treatment COVID-19 infections, especially for severe cases.•These data will also allow scientists and researchers to compare the immunological profiles of children with COVID-19 infection between different countries, especially with recent reports from Europe on the occurrence of Kawasaki-like syndrome, which was not observed in our Chinese cohort [@bib0003].

1. Data description {#sec0001}
===================

Children with COVID-19 infection confirmed by nasopharyngeal aspirate (NPA) SARS-CoV-2 reverse-transcriptase polymerase chain reaction (RT-PCR) were admitted to the Wuhan Children\'s Hospital between 21st January and 20th March 2020. Laboratory data were retrospectively retrieved from the patients' hospital record. The age and gender, as well as their haematological and immunological profiles were recorded (supplementary file), including their complete blood counts (total white cell count, haemoglobin concentration, platelet counts, absolute neutrophil, lymphocyte and monocyte counts), lymphocyte subset profiles (total CD3 T cell count, CD3CD4 helper T cell count, CD3CD8 cytotoxic T cell count, CD19 B cell count and CD16CD56 natural killer cell count), immunoglobulin profiles (IgG, IgA and IgM) and cytokine profiles (interleukin 2 (IL-2), IL-4. IL-6, IL-10, tumour necrosis factor alpha and interferon gamma levels).

[Table 1](#tbl0001){ref-type="table"} compared the haematological and immunological profiles between children with symptomatic and asymptomatic COVID-19 infection. Children with symptomatic COVID-19 infection had significantly lower haemoglobin levels, but higher absolute lymphocyte and monocyte counts, IgG and IgA levels, as well as interleukin 6 (IL-6), IL-10, tumour necrosis factor alpha and interferon gamma levels.Table 1Immunological profiles of children with symptomatic and asymptomatic COVID-19 infection.Table 1Symptomatic (*n* = 193)Asymptomatic (*n* = 51)MedianInterquarile RangeMissing dataMedianInterquarile RangeMissing datap-valueTotal white cell count(× 10^9^/L)6.765.37 - 8.27106.415.36 - 7.1640.15Haemoglobin (g/L)125115 - 13310132125 - 13840.0003Platelets (× 10^9^/L)287239 - 36810286247 - 33640.56Absolute Neutrophil Count (× 10^9^/L)2.361.72 - 3.49103.122.26 - 3.6940.05Absolute Lymphocyte Count (× 10^9^/L)2.971.97 - 4.5692.671.86 - 3.0840.04Absolute Monocyte Count (× 10^9^/L)0.430.35 - 0.59100.390.32 - 0.4840.02Total T Cells (CD3) (cells/uL)22461639 - 31973819701677 - 246460.08Helper T Cells (CD3CD4) (cells/uL)1172806 - 1820761122848 - 1395230.4Cytotoxic T Cells (CD3CD8) (cells/uL)1006680 - 128178991768 - 1183230.87B Cells (CD19) (cells/uL)618381 - 90039539432 - 64460.18NK Cells (CD16/56) (cells/uL)342199 - 50739257156 - 47460.11IgG (g/L)9.196.14 - 11.21410.058.75 - 11.6530.004IgA (g/L)1.010.33 - 1.69141.341.13 - 1.7430.005IgM (g/L)0.90.6 - 1.18140.890.69 - 1.3330.39IL2 (pg/ml)1.431.23 - 1.71361.331.15 - 1.5640.1IL4 (pg/ml)2.662.12 - 3.25362.461.95 - 3.2440.19IL6 (pg/ml)3.982.95 - 7.25363.532.59 - 4.3640.01IL10 (pg/ml)3.853.23 - 5.16363.082.70 - 3.454\<0.0001Tumour necrosis factor-alpha (pg/ml)1.71.24 - 2.20361.411.15 - 1.8940.04Interferon-gamma (pg/ml)3.012.39 - 4.25362.461.85 - 3.3840.004

2. Experimental design, materials and methods {#sec0002}
=============================================

Data were analysed using Microsoft Excel® (Redmond, Washington, USA) and GraphPad® Prism 8 (San Diego, California, USA). The median values and interquartile ranges were calculated. For comparison of data between the symptomatic and asymptomatic groups, the Mann--Whitney U test was used for continuous variables. A p-value of \<0.05 is considered as statistically significant.
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